Somnath Mukherjee: Evaluating Syphilis Diagnostic Platforms for Safer Blood Transfusions
Somnath Mukherjee, Professor at All India Institute of Medical Sciences Bhubaneswar, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our most recent publication focuses on transfusion-transmitted syphilis, which is becoming a concern due to the potential re-emergence of syphilis. Consequently, robust screening methods are essential to prevent the transmission of syphilis through blood transfusions. This paper provides a comparative evaluation of three diagnostic platforms for syphilis.
An interesting aspect of our findings is that Rapid Diagnostic Tests (RDTs) demonstrated superior diagnostic accuracy compared to VDRL, suggesting their potential utility as a supplementary method in resource-limited environments.”
Title: Prevalence and diagnostic accuracy of syphilis screening in blood donors: A prospective observational study comparing three different serological platforms
Authors: Ansuman Sahu, Nayana VK, Kavita Gupta, Debasish Mishra, Satya Prakash, Somnath Mukherjee
Read the Full Article on Vox Sanguinis․
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 14, 2026, 15:24Shiny K. Kajal: Why Blood from First-Degree Relatives is Not Recommended for Transfusion
-
Feb 14, 2026, 15:20Jake Mazan: 69 Million People in the UK Rely on Only 800,000 Blood Donors in Emergencies
-
Feb 14, 2026, 15:19Reza Shojaei: Beyond the Blood – Plasma Divide
-
Feb 14, 2026, 15:14Nour Al-Mozain: Blood Topics on Wikipedia – Scope, Accessibility, and Visibility
-
Feb 14, 2026, 15:01Beenish Abbas: Synergistic Tumor-Suppressive Effects of Vitamin K2 and Vitamin D in TNBC
-
Feb 14, 2026, 14:46Davide Capodanno: The Key Point Behind TUXEDO-2
-
Feb 14, 2026, 14:34Danny Hsu: The Diagnostic Challenge of Pulmonary Embolism During Pregnancy
-
Feb 14, 2026, 14:30Priyanka Raheja։ The Impact of Heavy Menstrual Bleeding in Rare Clotting Factor Deficiencies
-
Feb 14, 2026, 14:07Wolfgang Miesbach: Second-Longest Follow-Up of Intravenous AAV Gene Therapy in Hemophilia B